Farasat Zaman

Farasat Zaman

Senior Research Specialist
Visiting address: Bioclinicum J9:30, Akademiska stråket 1, 17164 Solna
Postal address: K6 Kvinnors och barns hälsa, K6 Barnendokrinologi Sävendahl, 171 77 Stockholm
Part of:

Research

  • *Osteoporosis and bone growth failure in chronic paediatric diseases* The overall aim of these studies is to address unanswered core bone health questions such as osteoporosis/bone growth failure in the paediatric patients with chronic diseases and exposed to high dose glucocorticoid therapy. Some 20% of paediatric patients treated with GCs experience multiple peripheral fractures, bone pain and vertebral compression fractures. We are currently investigating following disorders in which GCs are frequently used: * /Inflammation/ * /Acute Lymphoblastic Leukemia (ALL)/ * /Duchenne Muscular Dystrophy (DMD)/ Impaired bone health is often present at diagnosis in these disorders, but poorly understood Severe osteoporosis is a frequent finding 1-3 years post diagnosis. Understanding the pathophysiology of disordered bone health/osteoporosis following glucocorticoids treatement in chronic conditions such as ALL, inflammation and DMD will lead to development of better treatment strategies in affected children. We are also investigating novel molecules/peptides in combination with GCs to prevent osteoporosis and bone growth failure in infllamtion, ALL and DMD.

Articles

All other publications

Employments

  • Senior Research Specialist, Department of Women's and Children's Health, Karolinska Institutet, 2021-

Degrees and Education

  • Degree Of Doctor Of Philosophy, Department of Women's and Children's Health, Karolinska Institutet, 2010

News from KI

Events from KI